Blood donations and risk of coronary heart disease in men

A Ascherio1, E B Rimm, E Giovannucci

  • 1Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA. alberto.ascherio@channing.harvard.edu

Circulation
|January 4, 2001
PubMed

Insights

Reducing body iron stores through blood donation did not lower the risk of coronary heart disease (CHD). This study found no association between blood donation history and myocardial infarction or fatal CHD events.

Area of Science:

  • Cardiovascular disease epidemiology
  • Iron metabolism and health

Background:

  • Experimental studies suggest iron overload promotes atherosclerosis and ischemic myocardial damage.
  • Epidemiological studies on iron stores and coronary heart disease (CHD) risk have yielded inconsistent results.

Purpose of the Study:

  • To investigate whether reducing body iron stores by donating blood is associated with a lower risk of CHD.
  • To examine the relationship between lifetime blood donation history and the incidence of myocardial infarction and coronary heart disease mortality.

Main Methods:

  • Prospective study of 38,244 men from the Health Professionals Follow-up Study, free of cardiovascular disease in 1992.
  • Assessed lifetime history of blood donation via questionnaire; followed participants for 4 years for nonfatal myocardial infarctions and coronary deaths.
  • Analyzed the association between blood donation frequency and CHD risk, adjusting for potential confounders.

Main Results:

  • Blood donation was strongly associated with lower plasma ferritin levels, indicating reduced body iron stores.
  • No significant association was found between the number of lifetime blood donations and the risk of myocardial infarction or fatal CHD.
  • Relative risk of myocardial infarction for highest blood donation category was 1.2 (95% CI 0.8-1.8), unchanged after adjustments.

Conclusions:

  • The findings do not support the hypothesis that reducing body iron stores through blood donation lowers the risk of coronary heart disease.
  • Further research may be needed to fully elucidate the complex relationship between iron status and cardiovascular health.
Abstract

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...